Circular RNAs (circRNA) that form through non-canonical backsplicing events of pre-mRNA transcripts are evolutionarily conserved and abundantly expressed across species. However, the functional relevance of circRNAs remains a topic of debate. In this study, we identified and characterized a circular RNA derived from Exon 2 and Exon 8 of the ANKRD12 gene, termed here as circANKRD12. We show that this circRNA is abundantly expressed in breast and ovarian cancers.
makes circRNAs long-acting regulators of cellular behavior and robust biomarkers [13, 14] . A growing body of evidence has implicated functional involvement of circRNAs in regulating cancer progression and proliferation [8, 15, 16] .
In the present study, we investigated the functional role of a high abundance circRNA from Ankyrin Repeat Domain 12 (ANKRD12) gene in cancer progression. ANKRD12 is a paralog of ANKRD11, a putative tumor suppressor gene with multiple functions including as a p53 co-activator [17, 18] . Low ANKRD12 level is an independent prognostic predictor of colorectal carcinoma patients [19] . Circular isoforms of ANKRD12 have been identified in cancer cells and patient samples in many recent studies including ours [20, 21] . In this study, we validated one of the most predominant circular isoform of ANKRD12 gene that includes the backsplice junction of exons 8 and 2 (circANKRD12). We report that circANKRD12 regulates the invasion, migration proliferation and cellular bioenergetics of cancer cells by modulating cell signaling, metabolic and cell cycle regulation pathways in cancer. We confirmed the expression of this circRNA across a variety of cancer cell lines and provide evidence for its functional relevance through downstream regulation of several tumor invasion genes. 
MATERIALS AND METHODS

Cell Lines and treatment
RNA preparation and qRT-PCR
The nuclear and cytoplasmic RNA were extracted using The SurePrep™ Nuclear or Cytoplasmic RNA Purification Kit (Fisher Grand Island, NY, USA). Total RNA from whole-cell lysates by using RNAesay mini kit (Qiagen Valencia, CA USA). For RNAse R treatment, 2 μ g of total RNA was incubated 60 min at 40 °C with or without 3 U μ g −1 of RNAse R (Epicentre Technologies, Madison, WI), and the resulting RNA was subsequently purified using an RNeasy MinElute cleaning Kit (Qiagen, Valencia, CA USA). cDNA synthesis was carried out using First strand synthesis kit (AMV) from Roche Biosciences or Biorad select cDNA synthesis kit using random primer for circRNA experiments. Fast Start Universal SYBR Green Master mix (Roche, Clovis, CA) was used to amplify the specific gene using cDNA primes obtained from Primer bank (http://pga.mgh.harvard.edu/primerbank/ (Supplementary Table 1 ). Each Real-Time assay was done in triplicate on Step One Plus Real time PCR machine (Life Technologies, CA, USA).
Transfection
siRNA transfection was carried out using custom designed siRNAs for both ANKRD12 circular and linear transcripts (Fig 2 and Supplementary Table 1 ). The SKOV3, MDA-MB-231, OVCAR3, NCI-H226 cells were grown in 6 well plates for transfection. The cells were transfected at 24h with 30pmol concentration of siRNA (VWR, Radnor, PA, USA) or scrambled control (Mission siRNA universal negative control, Sigma, St.Louis, USA) using Lipofectamine RNAi max (Invitrogen MA USA) according to manufacturer's protocol. These experiments were conducted in three different biological triplicates for subsequent RNA-sequencing. SKOV3, OVCAR3, NCI-H226, MDA-MB-231 cells transfected with cirANKRD12 or universal scrambled control were used for RNAseq analysis. RNA-seq library preparation and In silico detection of circRNA candidates from paired end RNA-seq data was conducted as described earlier [20] 
RNAseq Analysis
Cell proliferation assay
Cells were cultured at a density of 5x10 3 cells per well in flat-bottomed 96-well plates and supplemented with 10% DMEM with antimycotic antibiotic. Experiment was done at different time points (24 h and 48 h or based on cell doubling time). CellTiter 96® Aq ueous One Solution Reagent (Promega, Madison, WI) was added and experiment was conducted according to the manufacturer's instructions.
CellTiter-Glo assay (Promega Madison USA): experiment was conducted according to the manufacturer's instructions. Briefly, CellTiter-Glo reagent was added directly to the wells of 96 well plate and luminescence was measured on an Envision reader (PerkinElmer).
Scratch assay-cell migration assay
The scratch assay was conducted as described earlier [22] . Cells were plated into a 6well plate with complete medium and grown to 80% confluence. Cells were transfected with respective siRNA in OPTIMEM medium, and the medium was replaced with serum free DMEM after transfection. After cells were grown to 100% confluence, a wound was created by scraping the confluent monolayer cells with a p200 pipette tip.
Cells were then grown either in serum free medium or medium containing 3mM
Thymidine. The distance between the two sides of cell-free area was photographed using 10x objective in an AXION Zeiss epiflurescence microscope. The distance is measured using Zeiss Zen software (Carl Zeiss Carpenteria, CA, USA) 2.7. Trans-well migration and invasion assay Cellular migration and invasion was determined using a Trans well Boyden chamber assay as described previously [23] .
3D organotypic spheroid Model experiments
3D anchorage independent spheroids were developed in SKOV3 cancer cell lines;
initially cells were seeded on ultra-low attachment plate (Corning, NY, USA) for 3 days to facilitate spheroid formation. Transfection of the spheroids with circANKRD12 siRNA was conducted using the reverse transfection method.
Spheroid area measurement
Cells were seeded at a density of 300 000 cells/well into ultralow attachment plats.
After 72h, cells were transfected either with scrambled siRNA or circANKRD12 siRNA.
After 48h the diameters of at least 50 spheroids were measured and spheroid area was measured Zeiss Zen Software.
Cell Proliferation assay in 3D organotypic models
10000 cells were seeded on each well of ultra-low attachment 96 well plate with OPTIMEM medium. After three days, once spheroids were formed, transfection was conducted with circANKRD12 sirRNA or scrambled control. After 24h and 48h of transfection, MTS reagent was added to the medium. Measurements were according to manufacturer's instructions.
2.11. Collagen Invasion assay in 3D organotypic models.
3D organotypic models of either circANKRD12 transfected or scrambled control SKOV3 cells expression GFP were placed of the top of jellified collagen matrix (Rat tail collagen1, 1mg/ml). The invasiveness analyzed after 24h to 10 days.
Cell Cycle Analysis
Cell cycle analysis was done on cells fixed with FxCycle™ PI/RNase Staining Solution using BD LSRFortessa™ cell analyzer. Cells were seeded on 60mm petri plates and transfection was done with siRNA of circANKRD12, or ANKRD12 mRNA. Cells were harvested on an interval of 48h (doubling Time). Experiment was extended till 10 th doubling time (20days). The silencing efficacy was measured by gene expression analysis (RT-PCR).
Western Blot Analysis
Assessment of mitochondrial function by seahorse extracellular flux analyzer
The mitochondrial oxygen consumption rate (OCR) in the MDA-MB-231 and SKOV3 cells was assessed by using a Seahorse Bioscience XFe96 analyzer (Massachusetts, USA). Seahorse Bioscience XF Cell Mito Stress Test assay kit was used for the study [22] . Experiments were conducted as per manufactures protocol. 10000 cells were seeded on assay plate and assay was completed in 48 hours after the transfection.
Statistical Analysis
Statistical analysis in all the experiments is based on at least three biological replicates and the error bars are drawn with standard error of means (SEM). The p value is calculated by using student's T test.
RESULTS
Characterization of circANKRD12 in cancer cells
We characterized the circular RNA expression using RNA sequencing (RNA-seq) of total RNA in ovarian cancer cell lines (SKOV3 and CAOV3) undergoing Epithelial to Mesenchymal Transition. Using our circRNA detection pipeline [20] , we identified a total of ~18,700 circRNAs in these cell lines. The circRNA from ANKRD12 gene having a backsplice junction between exons 8 and 2 (circANKRD12) was one of the highly abundant circular RNAs in both SKOV3 and CAOV3 cell lines. The circANKRD12 originates from 18p11.22 chromosome locus with the backsplice junction forming between exons located ~39.3kb apart (Fig 1a) . By carefully designing two sets of divergent primer pairs in Exon2 and Exon8 and sanger sequencing of the amplified products, we were able to identify two circular isoforms of 286bp and 925bp lengths sharing the same backsplice junction (Supplementary File 2-S2:1-3), Supplementary Table 2 ). The first isoform of 286bp is comprised of only two exons (Exon2 and Exon8), while the 925bp isoform is comprised of 6 exons (Exons 2,3,5,6,7 and 8). All subsequent functional studies do not distinguish between these two circular isoforms as they targeted the junction sequence that is unique to circular forms vis-à-vis linear forms.
Multiple validation experiments were used to confirm circANKRD12 expression ( Fig 1   b-d ). Divergent primers were designed to amplify the backsplice exon junction. As expected, each primer pair produced a single distinct band of expected product size in RT-PCR assay indicating the presence of the circular junction. The backsplice junctional sequence was confirmed by Sanger sequencing. The divergent primers, with respect to genomic sequence, only amplified when cDNA was used as a template. The same primers did not produce a product from genomic DNA (gDNA).
Conversely, PCR using convergent primers with respect to genomic sequence could amplify both cDNA and gDNA templates from ANKRD12 gene (Fig 1b) . This strongly indicates that a head-to-tail backsplicing junction in circANKRD12 only exists in the RNA form.
To examine whether circANKRD12 is resistant to exonucleases, we treated the total RNA extracted from the SKOV3 cell line with RNase R. This exoribonuclease enzyme digests all linear RNA forms with a 3' single stranded region of greater than 7 nucleotides [24] . As circRNAs are devoid of any 3' single strand overhangs, they are expected to show resistance to digestion by RNase R. Indeed, circANKRD12 was resistant to RNase R digestion compared to linear forms of ANKRD12, HIF1 alpha and GAPDH. Resistance to digestion with RNase R exonuclease confirmed that the circANKRD12 is a stable circularized transcript (Fig 1c) . Further, cDNA created by priming with oligo (dT) primers failed to produce any PCR amplification products for circANKRD12. On the other hand, priming with random hexamers, resulted in distinct PCR bands for the backsplice junction shows circANKRD12 is not poly A tailed ( Fig   1d) . The RT-PCR analysis of nuclear and cytoplasmic fractions of RNA demonstrated that ANKRD12 circRNA is predominantly localized in the cytoplasm (Fig 1e,f) . The purity of cytoplasmic and nuclear fractions was confirmed by amplifying the fractions using nuclear and cytoplasmic specific markers supplementary File 2 (S2:8)
We performed Real-time PCR analysis on 12 different cell lines from breast, ovarian and lung cancer and normal breast and lung to assess the cell-type specific expression of circANKRD12 (Fig 1g) . Most of these cell lines show a high abundance of both ANKRD12 circRNA and mRNA. Ovarian cancer cell lines show a higher abundance of ANKRD12 circRNA compared to breast and lung cancer cell lines.
siRNA-mediated knockdown of circANKRD12 is highly specific
To investigate the role of circANKRD12, we designed siRNAs to target the backsplice junction (Fig 2a) and transfected multiple cancer cell lines to induce siRNA-mediated knockdown of the circle while leaving the linear RNA unaffected. The circRNA specific siRNA was designed against the backsplice junction spanning exons 2 and 8 of the gene. We observed high knockdown efficiency of greater than 90% of the circular junction when using the siRNA versus the control (scrambled siRNA) in the four celllines (Fig 2b) . Using two siRNA constructs against the circANKRD12, we confirmed that knockdown of the circular RNA is specific and has no significant effect on the linear mRNA expression (Fig 2c) . We also designed siRNAs targeting exon9 and exon7 of ANKRD12 gene to knockdown the linear mRNA. Indeed, the siRNA designed against exon 9, which lies outside the circANKRD12 locus was successful at knocking down the mRNA and exhibits no effect on circANKRD12 levels (Fig 2d) . We investigated the specificity of siRNA constructs designed against circANKRD12, Exon7 and Exon9 through a series of knockdown experiments explained in supplementary File 2 (S2:4-7).
Silencing of circANKRD12 changes molecular phenotypes of ovarian, breast and lung cancer cells
RNA-sequencing was performed in triplicate for two ovarian cancer cell lines (SKOV3, OVCAR3), breast (MDA-MB-231) and a lung cancer cell line (NCI-H226) for both scrambled control and siRNA targeting circANKRD12. Table 1 gives the number of differentially expressed genes in circANKRD12 knockdown samples (Supplementary File S1) at a false discovery rate of less than 5% with at least 1.5-fold changes in expression. Table 4 ). IPA predicts a significant activation of interferon signaling pathway through upregulation of STAT1, STAT2, IFT1, MX1genes, and downregulation of estrogen mediated S phase entry through downregulating cyclin D1 and cyclin A. Activation of IL8 signaling and inflamasome pathways, closely associated with immune modulation is also predicted.
IL8 signaling pathway upregulates IL8, IRAK, ICAM-1, COX-2 and VEGF genes there by upregulating angiogenesis, inflammation, and inhibits cell proliferation by downregulating cyclin D1. The differentially regulated genes cyclin D1 (CCND1), CBX5, STAU1 and AK4 were found to be consistently downregulated in the circANKRD12 knockdown across multiple cell lines (Fig 3a) . Using qRT-PCR, we validated the differential expression of few selected genes in SKOV3 cells (Fig 3c) .
The gene cyclin D1 (CCND1) was among the genes that showed consistent downregulation in the circANKRD12 knockdown across multiple cell lines (Fig 3a) . To ensure that the effect on CCND1 is related to circANKRD12 knockdown rather than off-target effects we compared the knockdown effects in SKOV3 (High in circANKRD12 and high in CCDN1) and LL24 cells (low in circANKRD12 and high in CCDN1) (Fig 3b) . Unlike SKOV3 cells, the circANKRD12 level is low in LL24 cell line, attempts at knocking down circANKRD12 should not affect the cyclin D1 level in the cell line. Indeed, transfection of the siRNA against circANKRD12 in LL24 showed reduction of the already low levels of circANKRD12 but no effect on cyclin D1 expression, suggesting the siRNA effect on CCND1 is likely mediated through circANKRD12. Because cell cycle regulation seems to be one of the most deregulated pathways in circANKRD12 silenced cells, we decided to follow it up with further functional screening using cell based phenotypic assays.
Abrogation of circANKRD12 by siRNA mediated silencing increases migration and invasion in ovarian cancer cells
Wound healing assays show that silencing of cirANKRD12 increased cell migration (Fig 5a b , Supplementary File2-S2:10), in SKOV3 cells after 24h. compared to scrambled control. This is confirmed again by cell migration assays in synchronized (Thymidine incorporation) cells, which show an increased migration rate for circANKRD12 silenced SKOV3 cells (Fig 5c) . Matrigel invasion (inserts coated with matrigel) and migration analysis using Boyden chamber shows circANKRD12 silenced cells undergo significant increase in the invasion and migration compared to scrambled control (Supplementary File 2-S2:10).
Silencing of circANKRD12 decreases cell proliferation
Knockdown of circANKRD12 and ANKRD12 mRNA significantly reduces cell proliferation (Fig 5, Supplementary File 2-S2:9 ). The results of MTS and ATP assays show a significant reduction in cell proliferation in circANKRD12 silenced cells compared to scrambled control (Fig 5e, f) . The Trypan blue exclusion assays confirm the silencing of circANKRD12 is not affecting the cell viability significantly. However, silencing of ANKRD12 mRNA significantly reduces both proliferation and cell viability in SKOV3 cells (Fig 5d) . These results indicate that knockdowns of both circular and linear RNA forms of ANKRD12 gene are capable of inducing strong phenotypic changes and modulate the growth or survival of cancer cells.
Silencing of cirANKRD12 in 3D tumor models induces a phenotypic switch from highly proliferative to invasive phenotype
Since 3D culture is known to have better cell-to-cell interactions and more closely mimics tumors in vivo [25] , we investigated the effects of circANKRD12 knockdown in 3D culture experiments. The 3D anchorage independent growth of siRNA transfected SKOV3 cells showed smaller, dense aggregates associated with an invasive phenotype (Supplementary File 2-S2:12). This reduction in spheroid size in circANKRD12-silenced SKOV3 organotypic models results in an alteration of phenotype from less invasive to a more invasive one (Fig 6b) . Cell proliferation MTS assay reveals a significant reduction in cell growth within a time period of 24 hours and 48 hours after knockdown of ANKRD12 circRNA (Fig 6c) . Collagen invasion of the circANKRD12 silenced spheroids results in an increased invasion through the collagen gel with highly motile cells after 10 days of transfection (Fig 6d) . These results indicate the phenotypic switching from a highly proliferative phenotype to a less proliferative phenotype with high invasion potential. qRT-PCR analysis shows cyclin D1 expression is down regulated at least until 48 hours after transfection with the siRNA (Fig 7a) . This is also supported by the western blot analysis, which shows a reduction in cyclin D1 protein level (Fig 7b) . Only cyclin D1 shows differential regulation at the protein level in circANKRD12 silenced cells compared to other cyclin members including cyclin E1, pB1 and D2 (supplementary The longevity, initially stable for 6 days (supplementary File 2-S2:14) was checked on a cell doubling time basis estimated to be 48 hours (see Methods). The si-circANKRD12 exhibits an extended longevity period in SKOV3 cells, approaching 9 doublings (18 days). The reduction in the level of cyclin D1 is on par with the observed silencing efficiency and longevity of siRNA (Fig 7c) . After the 10 th doubling, the effect on cell proliferation induced by silencing of circANKRD12 becomes insignificant ( Fig   7d) , suggesting that the knockdown efficiency is lost due to multiple passages of cells.
Cyclin D1 is regulated in circANKRD12 silenced cells and involved in phenotypic switching by facilitating G1 arrest
As cyclin D1 is involved in cell cycle progression [26] , cell cycle analysis of circANKRD12 knockdowns was conducted. Cell cycle analysis using FACS indicate there is a significant G0/G1 cell cycle arrest in SKOV3 cells silenced with circANKRD12 compared to scrambled control (Fig 8a, b ).
Silencing of circANKRD12 affects Oxygen Consumption Ratio (OCR) in SKOV3 and MDAMB231 cells
AMPK signaling and other metabolic pathways are affected in circANKRD12 knockdown cancer cells (Supplementary Table 4 ). In order to determine whether the altered gene expression of these pathways translates to changes in basic metabolism, we analyzed metabolic phenotypes of circANKRD12 silenced MDA-MB-231 and SKOV3 cells using Seahorse extracellular flux analyzer. The oxygen consumption ratio (OCR) and ATP linked OCR analysis shows that knockdown of circANKRD12 decreases oxidative phosphorylation (OXPHOS) of MDAMB231 cells and SKOV3 cells (Fig 8 c-e ). Previous reports have suggested that high invasive potential of cancer cells is negatively correlated to high energetic cancer phenotype [27, 28] . These results thus indicate that circANKRD12 silencing can induce phenotypic switching between highly proliferative cells to highly invasive cells through shifting the oncobioenergetics to a low energy phenotype to facilitate invasion.
DISCUSSION
Circular RNAs are attracting greater attention in RNA biology as there is growing evidence for their role in gene expression regulation. Even though a large repertoire of circRNAs has been identified in different organisms, tissues, diseases and developmental conditions, only a few have been evaluated for their role in cellular functions [29] [30] [31] [32] . Functional screening using siRNA targeting is difficult for circRNAs compared to other RNA types as the choice of target region is limited to a few base pairs with specificity only at the backsplice junction. This constraint severely restricts the scale of circRNAs suitable for further functional studies using siRNA-mediated knockdown approaches.
In this study, we identified and characterized circular RNA isoforms from ANKRD12 gene (circANKRD12) that are abundantly expressed in ovarian and breast cancer cells. We showed that circANKRD12 is a stable circularized transcript, resistant to RNase R digestion and devoid of a polyA tail. In contrast to the linear mRNA form, which is predominantly nuclear, circANKRD12 is localized in the cytoplasm Differential gene expression analysis by RNA-seq of circANKRD12 silenced cells revealed that silencing may accelerate cancer cell invasion, migration and cellular movement by regulating a cascade of genes involved in these processes (supplementary Table 3 , 5) . Interferon signaling and cell cycle checkpoint regulation (G1/S) transition are top networks deregulated in cirANKRD12-silenced cells Cell proliferation was significantly arrested without any change in cell viability in circANKRD12 silenced SKOV3 cells. Cyclin D1, a consistently affected gene by circANKRD12 silencing, is down regulated thereby reducing cell proliferation and increasing invasion. Previous studies have reported a reduction in cyclin D1 levels and G0/G1 cell cycle stage arrest leads to an increase in migratory activities of MDA-MB-231 breast cancer cells [33] . Consistent with these findings, our results of cell cycle analysis also show a substantial G0/G1 arrest with increased migration and invasion in circANKRD12 knockdown cells. The migration and invasion assays significantly correlate with gene expression analysis and indicate an augmented cell migration and invasion rate. The 3D anchorage independent organotypic tumor models of SKOV3
show similar patterns of phenotypic characterization where invasion through collagen is increased upon silencing of circANKRD12. There is a strong phenotypic alteration after silencing circANKRD12 in the ovarian cancer cells in both 2D and 3D culture conditions suggesting that circANKRD12 is important in regulating proliferation, invasion and migration.
The Ankyrin Repeat Domain family of genes can act as putative tumor suppressors via p53 mediated feedback or through recruiting histone deacetylases (HDACs) to the p160 coactivator to repress transcriptional activities [17, 18, 34] . A clinical study of gene expression of ANKRD12 in colorectal cancer revealed that low ANKRD12 expression is correlated with overall poor survival and liver metastasis of CRC patients [19] .
We observed that the silencing of ANKRD12 mRNA reduces cell proliferation, induces cell death and down regulates cyclin D1. On the contrary, silencing of circANKRD12 arrests the cell cycle progression and increases tumor invasion without significantly affecting cell viability. The knockdown of cirANKRD12 can change the oncobioenegetics as its shift from a higher OXPHOS to a lower OXPHOPS phenotype which is highly invasive. circANKRD12 may act as competing endogenous RNA (ceRNA) to regulate a circRNA-miRNA-mRNA network. Our insilco analysis confirms that cyclin D1 and circANKRD12 have shared binding sites for several different microRNAs [ Supplementary Table 6 ]. Our preliminary analysis shows overexpression of hsa-miR-4768-5p reduces the level of Cyclin D1 by 20% (hsa-miR-4768-5p has common binding sites for circANKRD12 and Cyclin D1) (Data not shown). Thus, circANKRD12 could act as a microRNA sponge to regulate cyclin D1 levels.
In conclusion, our study provides the molecular, phenotypic and metabolic characterization of one of the most abundant circRNA in human ovarian and breast cancer cells. Our results suggest that circANKRD12 could be involved in a diverse set of functions ranging from cell cycle arrest, tumor invasion to immune modulation.
Manipulating the levels of circANKRD12 can regulate molecular functions by altering different signaling pathways and modifies the phenotype of the cells. The distinctive change from a proliferative to a more invasive phenotype by altering cirANKRD12 levels could lead to a future circRNA based therapeutic intervention in cancer. 
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